These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
721 related articles for article (PubMed ID: 20630773)
21. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients. Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581 [TBL] [Abstract][Full Text] [Related]
22. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis. Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218 [TBL] [Abstract][Full Text] [Related]
23. Multimodality MRI and MRA for decision making in minor stroke: a case with internal carotid and distal middle cerebral artery occlusion. Beitzke M; Enzinger C; Beitzke D; Niederkorn K; Offenbacher H; Niederkorn-Duft M; Fazekas F J Neuroimaging; 2011 Apr; 21(2):e156-8. PubMed ID: 20572908 [TBL] [Abstract][Full Text] [Related]
24. Successful intravenous thrombolysis in a 14-year-old boy with ischemic stroke. Sampaio I; Abecasis F; Quintas S; Moreno T; Camilo C; Vieira M; Pinho e Melo T; Correia M Pediatr Emerg Care; 2011 Jun; 27(6):541-3. PubMed ID: 21642792 [TBL] [Abstract][Full Text] [Related]
25. Timing of recanalization and outcome in ischemic-stroke patients treated with recombinant tissue plasminogen activator. Wei XE; Zhao YW; Lu J; Li MH; Li WB; Zhou YJ; Li YH Acta Radiol; 2015 Sep; 56(9):1119-26. PubMed ID: 25182802 [TBL] [Abstract][Full Text] [Related]
26. Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction. Deguchi I; Takeda H; Furuya D; Dembo T; Nagoya H; Kato Y; Ito Y; Fukuoka T; Maruyama H; Tanahashi N J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):108-13. PubMed ID: 20851627 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of blood pressure variability after thrombolysis in acute stroke. Delgado-Mederos R; Ribo M; Rovira A; Rubiera M; Munuera J; Santamarina E; Delgado P; Maisterra O; Alvarez-Sabin J; Molina CA Neurology; 2008 Aug; 71(8):552-8. PubMed ID: 18550860 [TBL] [Abstract][Full Text] [Related]
28. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit. Yoneda Y; Yamamoto S; Hara Y; Ohta K; Matsushita M; Yamamoto D; Yamashita H; Hosoda K Clin Neurol Neurosurg; 2007 Sep; 109(7):567-70. PubMed ID: 17573188 [TBL] [Abstract][Full Text] [Related]
29. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization. Sangha N; El Khoury R; Misra V; Lopez G J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118 [TBL] [Abstract][Full Text] [Related]
30. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke. Kimura K; Iguchi Y; Yamashita S; Shibazaki K; Kobayashi K; Inoue T J Neurol Sci; 2008 Apr; 267(1-2):57-61. PubMed ID: 17964602 [TBL] [Abstract][Full Text] [Related]
31. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital. Hsu YC; Sung SF; Ong CT; Wu CS; Su YH Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569 [TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke. Arenillas JF; Ispierto L; Millán M; Escudero D; Pérez de la Ossa N; Dorado L; Guerrero C; Serena J; Castillo J; Dávalos A Neurology; 2008 Jul; 71(3):190-5. PubMed ID: 18625965 [TBL] [Abstract][Full Text] [Related]
33. [Thrombolytic therapy in cerebral infarction]. Varga V; Waje-Andreassen U; Naess H; Lundstadsveen MT; Thomassen L Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2214-7. PubMed ID: 19898567 [TBL] [Abstract][Full Text] [Related]
35. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients. Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014 [TBL] [Abstract][Full Text] [Related]
36. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260 [TBL] [Abstract][Full Text] [Related]
37. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy]. Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535 [TBL] [Abstract][Full Text] [Related]
38. Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study. Messé SR; Kasner SE; Cucchiara BL; Demchuk A; Tanne D; Ouyang B; Levine SR; J Stroke Cerebrovasc Dis; 2011; 20(3):236-40. PubMed ID: 20656508 [TBL] [Abstract][Full Text] [Related]
39. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke. Kim DH; Lee DS; Nah HW; Cha JK BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461 [TBL] [Abstract][Full Text] [Related]
40. Treatment of acute ischemic brain infarction with the assistance of local intraarterial thrombolysis with recombinant tissue-type plasminogen activator. Poncyljusz W; Falkowski A; Kojder I; Cebula E; Sagan L; Czechowski J; Walecka A Acta Radiol; 2007 Sep; 48(7):774-80. PubMed ID: 17729010 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]